Cargando…

Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy

Background: The guidewire (GW) plays an important role in pancreatobiliary endoscopy. GW quality is a critical factor in the effectiveness and efficiency of pancreatobiliary endoscopy. In this study, we evaluate a new 0.025 inch multipurpose endoscopic GW: the M-Through. Methods: Our study was a mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Shigeto, Fujisawa, Toshio, Isayama, Hiroyuki, Asahara, Shingo, Ogiwara, Shingo, Okubo, Hironao, Yamagata, Hisafumi, Ushio, Mako, Takahashi, Sho, Okawa, Hiroki, Yamagata, Wataru, Okawa, Yoshihiro, Suzuki, Akinori, Takasaki, Yusuke, Ochiai, Kazushige, Tomishima, Ko, Saito, Hiroaki, Shiina, Shuichiro, Ikari, Takaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765498/
https://www.ncbi.nlm.nih.gov/pubmed/33339093
http://dx.doi.org/10.3390/jcm9124059
_version_ 1783628504199331840
author Ishii, Shigeto
Fujisawa, Toshio
Isayama, Hiroyuki
Asahara, Shingo
Ogiwara, Shingo
Okubo, Hironao
Yamagata, Hisafumi
Ushio, Mako
Takahashi, Sho
Okawa, Hiroki
Yamagata, Wataru
Okawa, Yoshihiro
Suzuki, Akinori
Takasaki, Yusuke
Ochiai, Kazushige
Tomishima, Ko
Saito, Hiroaki
Shiina, Shuichiro
Ikari, Takaaki
author_facet Ishii, Shigeto
Fujisawa, Toshio
Isayama, Hiroyuki
Asahara, Shingo
Ogiwara, Shingo
Okubo, Hironao
Yamagata, Hisafumi
Ushio, Mako
Takahashi, Sho
Okawa, Hiroki
Yamagata, Wataru
Okawa, Yoshihiro
Suzuki, Akinori
Takasaki, Yusuke
Ochiai, Kazushige
Tomishima, Ko
Saito, Hiroaki
Shiina, Shuichiro
Ikari, Takaaki
author_sort Ishii, Shigeto
collection PubMed
description Background: The guidewire (GW) plays an important role in pancreatobiliary endoscopy. GW quality is a critical factor in the effectiveness and efficiency of pancreatobiliary endoscopy. In this study, we evaluate a new 0.025 inch multipurpose endoscopic GW: the M-Through. Methods: Our study was a multicenter retrospective analysis. We enrolled patients who underwent endoscopic procedures using the M-Through between May 2018 and April 2020. Patients receiving the following endoscopic treatments were enrolled: common bile duct (CBD) stone extraction, endoscopic drainage for distal and hilar malignant biliary obstruction (MBO), and endoscopic drainage for acute cholecystitis. For each procedure, we examined the rate of success without GW exchange. Results: A total of 170 patients (80 with CBD stones, 60 with MBO, and 30 with cholecystitis) were enrolled. The rate of completion without GW exchange was 100% for CBD stone extraction, 83.3% for endoscopic drainage for MBO, and 43.3% for endoscopic drainage for cholecystitis. In unsuccessful cholecystitis cases with the original GW manipulator, 1 of 8 cases succeeded in the manipulator exchange. Including 6 cases who changed GW after the manipulator exchange, 11 of 16 cases succeeded in changing GW. There was significant difference in the success rate between the manipulator exchange and GW exchange (p = 0.03). The insertion of devices and stent placement after biliary cannulation (regardless of type) were almost completed with M-through. We observed no intraoperative GW-related adverse events such as perforation and bleeding due to manipulation. Conclusion: The 0.025 inch M-Through can be used for endoscopic retrograde cholangiopancreatography-related procedures efficiently and safely. Our study found high rates of success without GW exchange in all procedures except for endoscopic drainage for cholecystitis. This GW is considered (1) excellent for supportability of device insertion to remove CBD stones; (2) good for seeking the biliary malignant stricture but sometimes need the help of a hydrophilic GW; (3) suboptimal for gallbladder drainage that require a high level of seeking ability.
format Online
Article
Text
id pubmed-7765498
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77654982020-12-27 Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy Ishii, Shigeto Fujisawa, Toshio Isayama, Hiroyuki Asahara, Shingo Ogiwara, Shingo Okubo, Hironao Yamagata, Hisafumi Ushio, Mako Takahashi, Sho Okawa, Hiroki Yamagata, Wataru Okawa, Yoshihiro Suzuki, Akinori Takasaki, Yusuke Ochiai, Kazushige Tomishima, Ko Saito, Hiroaki Shiina, Shuichiro Ikari, Takaaki J Clin Med Article Background: The guidewire (GW) plays an important role in pancreatobiliary endoscopy. GW quality is a critical factor in the effectiveness and efficiency of pancreatobiliary endoscopy. In this study, we evaluate a new 0.025 inch multipurpose endoscopic GW: the M-Through. Methods: Our study was a multicenter retrospective analysis. We enrolled patients who underwent endoscopic procedures using the M-Through between May 2018 and April 2020. Patients receiving the following endoscopic treatments were enrolled: common bile duct (CBD) stone extraction, endoscopic drainage for distal and hilar malignant biliary obstruction (MBO), and endoscopic drainage for acute cholecystitis. For each procedure, we examined the rate of success without GW exchange. Results: A total of 170 patients (80 with CBD stones, 60 with MBO, and 30 with cholecystitis) were enrolled. The rate of completion without GW exchange was 100% for CBD stone extraction, 83.3% for endoscopic drainage for MBO, and 43.3% for endoscopic drainage for cholecystitis. In unsuccessful cholecystitis cases with the original GW manipulator, 1 of 8 cases succeeded in the manipulator exchange. Including 6 cases who changed GW after the manipulator exchange, 11 of 16 cases succeeded in changing GW. There was significant difference in the success rate between the manipulator exchange and GW exchange (p = 0.03). The insertion of devices and stent placement after biliary cannulation (regardless of type) were almost completed with M-through. We observed no intraoperative GW-related adverse events such as perforation and bleeding due to manipulation. Conclusion: The 0.025 inch M-Through can be used for endoscopic retrograde cholangiopancreatography-related procedures efficiently and safely. Our study found high rates of success without GW exchange in all procedures except for endoscopic drainage for cholecystitis. This GW is considered (1) excellent for supportability of device insertion to remove CBD stones; (2) good for seeking the biliary malignant stricture but sometimes need the help of a hydrophilic GW; (3) suboptimal for gallbladder drainage that require a high level of seeking ability. MDPI 2020-12-16 /pmc/articles/PMC7765498/ /pubmed/33339093 http://dx.doi.org/10.3390/jcm9124059 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ishii, Shigeto
Fujisawa, Toshio
Isayama, Hiroyuki
Asahara, Shingo
Ogiwara, Shingo
Okubo, Hironao
Yamagata, Hisafumi
Ushio, Mako
Takahashi, Sho
Okawa, Hiroki
Yamagata, Wataru
Okawa, Yoshihiro
Suzuki, Akinori
Takasaki, Yusuke
Ochiai, Kazushige
Tomishima, Ko
Saito, Hiroaki
Shiina, Shuichiro
Ikari, Takaaki
Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy
title Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy
title_full Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy
title_fullStr Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy
title_full_unstemmed Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy
title_short Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy
title_sort clinical evaluation of a newly developed guidewire for pancreatobiliary endoscopy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765498/
https://www.ncbi.nlm.nih.gov/pubmed/33339093
http://dx.doi.org/10.3390/jcm9124059
work_keys_str_mv AT ishiishigeto clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT fujisawatoshio clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT isayamahiroyuki clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT asaharashingo clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT ogiwarashingo clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT okubohironao clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT yamagatahisafumi clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT ushiomako clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT takahashisho clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT okawahiroki clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT yamagatawataru clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT okawayoshihiro clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT suzukiakinori clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT takasakiyusuke clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT ochiaikazushige clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT tomishimako clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT saitohiroaki clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT shiinashuichiro clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy
AT ikaritakaaki clinicalevaluationofanewlydevelopedguidewireforpancreatobiliaryendoscopy